PLANNED MAINTENANCE

There will be scheduled maintenance work beginning on Wednesday 26th February 2020 from 11:00 AM through to 12.00 PM (GMT).

During this time, you may not be able to log into ChemSpider. We apologise for any inconvenience this might cause and thank you for your patience.


ChemSpider 2D Image | Golvatinib | C33H37F2N7O4

Golvatinib

  • Molecular FormulaC33H37F2N7O4
  • Average mass633.688 Da
  • Monoisotopic mass633.287537 Da
  • ChemSpider ID17275597

More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

1,1-Cyclopropanedicarboxamide, N-[2-fluoro-4-[[2-[[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]amino]-4-pyridinyl]oxy]phenyl]-N'-(4-fluorophenyl)- [ACD/Index Name]
516Z3YP58E
928037-13-2 [RN]
9565
E7050
Golvatinib [INN] [USAN]
Golvatinib [Spanish] [INN]
Golvatinib [French] [INN]
Golvatinibum [Latin] [INN]
N-(2-Fluor-4-{[2-({[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl}amino)-4-pyridinyl]oxy}phenyl)-N'-(4-fluorphenyl)-1,1-cyclopropandicarboxamid [German] [ACD/IUPAC Name]
More...
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Safety:

      5 Axon Medchem 1959
      H303;H313;H317;H333;H334;H335;H373 Axon Medchem 1959
      no pictogram Axon Medchem 1959
      P101;P102;P103;P260;P262;P263;P264;P270;P280;P304;P312;P340 Axon Medchem 1959
      Warning Axon Medchem 1959
    • Bio Activity:

      c-Met/HGFR MedChem Express HY-13068
      c-Met/HGFR VEGFR MedChem Express HY-13068
      E7050(Golvatinib) is a dual c-Met and VEGFR-2 inhibitor with IC50 of 14 nM and 16 nM. MedChem Express
      E7050(Golvatinib) is a dual c-Met and VEGFR-2 inhibitor with IC50 of 14 nM and 16 nM.; IC50 value: 14/16 nM (c-Met/VEGFR2) [1]; Target: c-Met/VEGFR2; in vitro: In vitro studies indicate that E7050 potently inhibits phosphorylation of both c-Met and VEGFR-2. MedChem Express HY-13068
      E7050(Golvatinib) is a dual c-Met and VEGFR-2 inhibitor with IC50 of 14 nM and 16 nM.;IC50 value: 14/16 nM (c-Met/VEGFR2) [1];Target: c-Met/VEGFR2;In vitro: In vitro studies indicate that E7050 potently inhibits phosphorylation of both c-Met and VEGFR-2. E7050 also potently represses the growth of both c-met amplified tumor cells and endothelial cells stimulated with either HGF or VEGF [1]. E7050 circumvents resistance to all of the reversible, irreversible, and mutant-selective EGFR-TKIs induced by exogenous and/or endogenous HGF in EGFR mutant lung cancer cell lines, by blocking the Met/Gab1/PI3K/Akt pathway in vitro. E7050 also prevents the emergence of gefitinib-resistant HCC827 cells induced by continuous exposure to HGF [2].;In vivo: In vivo studies using E7050 shows inhibition of the phosphorylation of c-Met and VEGFR-2 in tumors, and strong inhibition of tumor growth and tumor angiogenesis in xenograft models. Treatment of some tumor lines containing c-met amplifications w MedChem Express HY-13068
      Protein Tyrosine Kinase/RTK MedChem Express HY-13068
      Protein Tyrosine Kinase/RTK; MedChem Express HY-13068

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module

Density: 1.4±0.1 g/cm3
Boiling Point: 867.5±65.0 °C at 760 mmHg
Vapour Pressure: 0.0±3.3 mmHg at 25°C
Enthalpy of Vaporization: 126.1±3.0 kJ/mol
Flash Point: 478.5±34.3 °C
Index of Refraction: 1.671
Molar Refractivity: 168.2±0.3 cm3
#H bond acceptors: 11
#H bond donors: 3
#Freely Rotating Bonds: 8
#Rule of 5 Violations: 2
ACD/LogP: 2.03
ACD/LogD (pH 5.5): -0.41
ACD/BCF (pH 5.5): 1.00
ACD/KOC (pH 5.5): 1.00
ACD/LogD (pH 7.4): 1.46
ACD/BCF (pH 7.4): 4.63
ACD/KOC (pH 7.4): 57.56
Polar Surface Area: 119 Å2
Polarizability: 66.7±0.5 10-24cm3
Surface Tension: 70.6±3.0 dyne/cm
Molar Volume: 450.0±3.0 cm3

Click to predict properties on the Chemicalize site






Advertisement